| Pan-cancer analysis of whole genomes Nature 578 (7793), 82-93, 2020 | 1657* | 2020 |
| Whole–genome characterization of chemoresistant ovarian cancer AM Patch, EL Christie, D Etemadmoghadam, DW Garsed, J George, ... Nature 521 (7553), 489-494, 2015 | 1475 | 2015 |
| Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing I Cortés-Ciriano, JJK Lee, R Xi, D Jain, YL Jung, L Yang, D Gordenin, ... Nature genetics 52 (3), 331-341, 2020 | 537 | 2020 |
| ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer RE Miller, A Leary, CL Scott, V Serra, CJ Lord, D Bowtell, DK Chang, ... Annals of Oncology 31 (12), 1606-1622, 2020 | 286 | 2020 |
| Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ... Cell 184 (8), 2239-2254. e39, 2021 | 281 | 2021 |
| The architecture and evolution of cancer neochromosomes DW Garsed, OJ Marshall, VDA Corbin, A Hsu, L Di Stefano, J Schröder, ... Cancer cell 26 (5), 653-667, 2014 | 187 | 2014 |
| Neutral tumor evolution? M Tarabichi, I Martincorena, M Gerstung, AM Leroi, F Markowetz, ... Nature Genetics 50 (12), 1630-1633, 2018 | 75 | 2018 |
| Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer DW Garsed, K Alsop, S Fereday, C Emmanuel, CJ Kennedy, ... Clinical Cancer Research 24 (3), 569-580, 2018 | 75 | 2018 |
| EIF1AX and NRAS Mutations Co-occur and Cooperate in Low-Grade Serous Ovarian Carcinomas D Etemadmoghadam, WJ Azar, Y Lei, T Moujaber, DW Garsed, ... Cancer Research 77 (16), 4268-4278, 2017 | 74 | 2017 |
| Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation M Kansara, H San Leong, DM Lin, S Popkiss, P Pang, DW Garsed, ... The Journal of clinical investigation 123 (12), 5351-5360, 2013 | 72 | 2013 |
| Going to extremes: determinants of extraordinary response and survival in patients with cancer FAM Saner, A Herschtal, BH Nelson, A deFazio, EL Goode, SJ Ramus, ... Nature Reviews Cancer 19 (6), 339-348, 2019 | 39 | 2019 |
| Combined burden and functional impact tests for cancer driver discovery using DriverPower S Shuai, S Gallinger, LD Stein Nature communications 11 (1), 734, 2020 | 37 | 2020 |
| The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer DW Garsed, A Pandey, S Fereday, CJ Kennedy, K Takahashi, K Alsop, ... Nature genetics 54 (12), 1853-1864, 2022 | 30 | 2022 |
| Survival Following Chemotherapy in Ovarian Clear Cell Carcinoma Is Not Associated with Pathological Misclassification of Tumor Histotype M Takenaka, M Köbel, DW Garsed, S Fereday, A Pandey, ... Clinical Cancer Research 25 (13), 3962-3973, 2019 | 30 | 2019 |
| PCAWG Evolution and Heterogeneity Working Group and the PCAWG Consortium. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes SC Dentro, I Leshchiner, K Haase, M Tarabichi, J Wintersinger, ... Cell 184 (8), 2239-54, 2021 | 25 | 2021 |
| Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival KK Brieger, S Peterson, AW Lee, B Mukherjee, KM Bakulski, A Alimujiang, ... Gynecologic oncology 158 (3), 702-709, 2020 | 20 | 2020 |
| Cancer‐associated neochromosomes: a novel mechanism of oncogenesis DW Garsed, AJ Holloway, DM Thomas Bioessays 31 (11), 1191-1200, 2009 | 18 | 2009 |
| Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer NL Burdett, MO Willis, K Alsop, AL Hunt, A Pandey, PT Hamilton, T Abulez, ... Nature genetics 55 (3), 437-450, 2023 | 17 | 2023 |
| A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions F Pedeutour, G Maire, A Pierron, DM Thomas, DW Garsed, L Bianchini, ... Virchows Archiv 461, 67-78, 2012 | 15 | 2012 |
| The tumor microenvironment of clear-cell ovarian canCer MJ Devlin, R Miller, F Laforets, P Kotantaki, DW Garsed, R Kristeleit, ... Cancer Immunology Research 10 (11), 1326-1339, 2022 | 13 | 2022 |
David BowtellBestätigte E-Mail-Adresse bei petermac.org
